Literature DB >> 12176337

Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1.

Michelle M Hill1, Jianhua Feng, Brian A Hemmings.   

Abstract

Protein kinase B (PKB/Akt) has been well established as an important signaling intermediate, and its deregulation has been implicated in the development of human cancer and diabetes (reviewed in). Full activation of PKB requires phosphorylation on residues Thr308 and Ser473. While the Thr308 kinase, named 3-phosphoinositide-dependent kinase-1 (PDK1), has been extensively characterized (reviewed in ), the identity of the Ser473 kinase remains unclear. We have focused our study on the plasma membrane (PM) fraction because membrane localization is sufficient to activate PKB, and this suggests that PKB upstream kinases are constitutively active at the membrane. Here, we report the identification of a constitutively active PKB Ser473 kinase activity enriched in buoyant, detergent-insoluble plasma membrane rafts that are distinct from the cytosolic distribution of PKB and PDK1. This Ser473 kinase activity was released from the membrane by high salt, and gel filtration analysis showed that the kinase responsible is present in a large complex of >500 kDa. Two major phosphoproteins and integrin-linked kinase (ILK) were detected in partially purified PKB Ser473 kinase preparations. In contrast to previous observations, however, ILK immunoprecipitates did not retain Ser473 kinase activity. Thus, we have identified a novel raft-associated PKB Ser473 kinase, implicating a role for lipid rafts in PKB signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176337     DOI: 10.1016/s0960-9822(02)00973-9

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  52 in total

Review 1.  The integrin-actin connection, an eternal love affair.

Authors:  Cord Brakebusch; Reinhard Fässler
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

Review 2.  Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm.

Authors:  Alexandra C Newton
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

Review 3.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 4.  Integrin signaling and mammary cell function.

Authors:  Franziska Schatzmann; Rebecca Marlow; Charles H Streuli
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

5.  Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells.

Authors:  Chohreh Partovian; Rong Ju; Zhen W Zhuang; Kathleen A Martin; Michael Simons
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

Review 6.  Targeting the PI3-kinase/Akt/mTOR signaling pathway.

Authors:  Burhan Hassan; Argun Akcakanat; Ashley M Holder; Funda Meric-Bernstam
Journal:  Surg Oncol Clin N Am       Date:  2013-08-06       Impact factor: 3.495

7.  Gonadotropin releasing hormone activation of the mTORC2/Rictor complex regulates actin remodeling and ERK activity in LβT2 cells.

Authors:  Brian S Edwards; William J Isom; Amy M Navratil
Journal:  Mol Cell Endocrinol       Date:  2016-09-20       Impact factor: 4.102

8.  Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression.

Authors:  Haidong Gao; Zhigang Yu; Dongsong Bi; Liyu Jiang; Yazhou Cui; Jingzhong Sun; Rong Ma
Journal:  Mol Cell Biochem       Date:  2007-06-19       Impact factor: 3.396

9.  The pseudoactive site of ILK is essential for its binding to alpha-Parvin and localization to focal adhesions.

Authors:  Koichi Fukuda; Sudhiranjan Gupta; Ka Chen; Chuanyue Wu; Jun Qin
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

10.  Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells.

Authors:  Boon Tin Chua; David Gallego-Ortega; Ana Ramirez de Molina; Axel Ullrich; Juan Carlos Lacal; Julian Downward
Journal:  Mol Cancer       Date:  2009-12-31       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.